0001213900-19-006016.txt : 20190409 0001213900-19-006016.hdr.sgml : 20190409 20190409090400 ACCESSION NUMBER: 0001213900-19-006016 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190409 DATE AS OF CHANGE: 20190409 EFFECTIVENESS DATE: 20190409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Therapix Biosciences Ltd. CENTRAL INDEX KEY: 0001611746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-336762 FILM NUMBER: 19738558 BUSINESS ADDRESS: STREET 1: 4 ARIEL SHARON STREET STREET 2: HASHAHAR TOWER, 16TH FLOOR CITY: GIV?ATAYIM STATE: L3 ZIP: 5320047 BUSINESS PHONE: 972-3-6167055 MAIL ADDRESS: STREET 1: 4 ARIEL SHARON STREET STREET 2: HASHAHAR TOWER, 16TH FLOOR CITY: GIV?ATAYIM STATE: L3 ZIP: 5320047 D 1 primary_doc.xml X0708 D LIVE 0001611746 Therapix Biosciences Ltd. 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIVATAYIM L3 ISRAEL 5320047 972-3-6167055 ISRAEL NasVax Ltd. None Other Limited Company true Ascher Shmulewitz 4 Ariel Sharon Street HaShahar Tower, 16th Floor Givatayim L3 ISRAEL 5320047 Executive Officer Director Chief Executive Officer and Chairman Oz Adler 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Executive Officer Chief Financial Officer Adi Zuloff-Shani 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Executive Officer Chief Technologies Officer Amit Berger 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Director Yafit Stark 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Director Zohar Heiblum 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Director Eric So 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Director Stephen Simes 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR Givatayim L3 ISRAEL 5320047 Director Other Health Care Decline to Disclose 06b false 2019-04-02 false true false 105000 None None None None NONE NONE NONE XX Unknown 00000 CA CALIFORNIA IL ILLINOIS NJ NEW JERSEY NY NEW YORK VT VERMONT true 2249986 2249986 0 false 8 0 0 0 false Therapix Biosciences Ltd. /s/ Oz Adler Oz Adler Chief Financial Officer 2019-04-09